Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4868787
Max Phase: Preclinical
Molecular Formula: C50H80N18O12
Molecular Weight: 1125.30
Molecule Type: Unknown
Associated Items:
ID: ALA4868787
Max Phase: Preclinical
Molecular Formula: C50H80N18O12
Molecular Weight: 1125.30
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CCC(=O)O)C(=O)N[C@@H](CCCNC(=N)NC(=O)NCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O
Standard InChI: InChI=1S/C50H80N18O12/c1-28(2)25-37(45(78)63-34(9-5-23-60-49(57)68-50(80)61-24-6-20-51)43(76)65-36(41(52)74)26-29-10-14-31(69)15-11-29)66-44(77)35(8-4-22-59-48(55)56)64-46(79)38(27-30-12-16-32(70)17-13-30)67-42(75)33(7-3-21-58-47(53)54)62-39(71)18-19-40(72)73/h10-17,28,33-38,69-70H,3-9,18-27,51H2,1-2H3,(H2,52,74)(H,62,71)(H,63,78)(H,64,79)(H,65,76)(H,66,77)(H,67,75)(H,72,73)(H4,53,54,58)(H4,55,56,59)(H4,57,60,61,68,80)/t33-,34-,35-,36-,37-,38-/m0/s1
Standard InChI Key: GQQOUWMFSIQFNW-JPRYDEJLSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1125.30 | Molecular Weight (Monoisotopic): 1124.6203 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Konieczny A, Conrad M, Ertl FJ, Gleixner J, Gattor AO, Grätz L, Schmidt MF, Neu E, Horn AHC, Wifling D, Gmeiner P, Clark T, Sticht H, Keller M.. (2021) N-Terminus to Arginine Side-Chain Cyclization of Linear Peptidic Neuropeptide Y Y4 Receptor Ligands Results in Picomolar Binding Constants., 64 (22.0): [PMID:34748345] [10.1021/acs.jmedchem.1c01574] |
Source(1):